April 1, 2016
A synthetic molecule developed by UT Southwestern research scientist David Corey’s laboratory may soon treat a rare, incurable genetic disease.
Friedreich’s ataxia is a progressive genetic neuromuscular disease that causes chronic fatigue, balance issues, slurred speech and eventually fatal heart problems. The Corey Lab is working on a treatment to bring hope to patients affected by FA.